Filing Details

Accession Number:
0001628280-23-035712
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-10-31 16:04:20
Reporting Period:
2023-10-27
Accepted Time:
2023-10-31 16:04:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1104506 Insmed Inc INSM Pharmaceutical Preparations (2834) 541972729
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1402051 William Lewis 700 Us Highway 202/206
Bridgewater NJ 08807
Chair And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-10-27 53,363 $14.24 53,363 No 4 M Indirect Indirect
Common Stock Disposition 2023-10-27 53,363 $24.04 0 No 4 S Indirect Indirect
Common Stock Acquisiton 2023-10-27 1,322 $14.24 1,322 No 4 M Indirect Indirect
Common Stock Disposition 2023-10-27 1,322 $25.08 0 No 4 S Indirect Indirect
Common Stock Acquisiton 2023-10-27 315 $14.24 315 No 4 M Indirect Indirect
Common Stock Disposition 2023-10-27 315 $26.00 0 No 4 S Indirect Indirect
Common Stock Acquisiton 2023-10-27 500 $14.24 500 No 4 M Indirect Indirect
Common Stock Acquisiton 2023-10-27 55,350 $14.24 289,274 No 4 M Indirect Indirect
Common Stock Disposition 2023-10-27 55,350 $24.04 233,924 No 4 S Indirect Indirect
Common Stock Acquisiton 2023-10-27 1,323 $14.24 235,247 No 4 M Indirect Indirect
Common Stock Disposition 2023-10-27 1,323 $25.05 233,924 No 4 S Indirect Indirect
Common Stock Acquisiton 2023-10-27 327 $14.24 234,251 No 4 M Indirect Indirect
Common Stock Disposition 2023-10-27 327 $26.00 233,924 No 4 S Indirect Indirect
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Indirect Indirect
No 4 S Indirect Indirect
No 4 M Indirect Indirect
No 4 S Indirect Indirect
No 4 M Indirect Indirect
No 4 S Indirect Indirect
No 4 M Indirect Indirect
No 4 M Indirect Indirect
No 4 S Indirect Indirect
No 4 M Indirect Indirect
No 4 S Indirect Indirect
No 4 M Indirect Indirect
No 4 S Indirect Indirect
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2023-10-27 55,000 $0.00 55,000 $14.24
Common Stock Stock Option (right to buy) Disposition 2023-10-27 500 $0.00 500 $14.24
Common Stock Stock Option (right to buy) Disposition 2023-10-27 57,000 $0.00 57,000 $14.24
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
500 2023-10-31 No 4 M Indirect
0 2023-10-31 No 4 M Indirect
0 2023-10-31 No 4 M Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 342,648 Direct
Footnotes
  1. This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  2. By ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A11/1/2020
  3. This is the weighted average sales price representing 53,363 shares sold at prices ranging from $23.68 to $24.60 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  4. This is the weighted average sales price representing 1,322 shares sold at prices ranging from $24.83 to $25.40 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  5. By ARTICLE 4 KATIE PROCTER DYNASTY TRUST
  6. This is the weighted average sales price representing 55,350 shares sold at prices ranging from $23.65 to $24.63 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  7. This is the weighted average sales price representing 1,323 shares sold at prices ranging from $24.83 to $25.40 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  8. Includes 1,303 shares acquired through the Company's 2018 Employee Stock Purchase Plan.
  9. The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable and were scheduled to expire on October 31, 2023.